Company Invivo Therapeutics Holdings Corp OTC Bulletin Board
Equities
NVIV
US46186M1009
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director/Board Member | 80 | 10-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,105,446 | 3,104,797 ( 99.98 %) | 0 | 99.98 % |
Company contact information
Invivo Therapeutics Holdings Corp.
Building 1400 West One Kendall Square
02139, Cambridge
+617 863 5500
http://www.invivotherapeutics.com![address Invivo Therapeutics Holdings Corp(NVIV)](https://cdn.zonebourse.com/static/address/6806106.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- NVIV Stock
- NVIV Stock
- Company Invivo Therapeutics Holdings Corp